Atlas FDA

Praxis Extended RAS Panel

FDA premarket approval P160038/S013 · decided 2019-08-08

Approval details

PMA number
P160038
Supplement
S013
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
Praxis Extended RAS Panel
Generic name
Next generation sequencing oncology panel, somatic or germline variant detection system
Applicant
Illumina, Inc.
Date received
2019-07-31
Decision date
2019-08-08
Days to decision
8 days
Decision code
OK30
Product code
PQP
Advisory committee
Pathology
Expedited review
No
Location
San Diego, CA
Statement
Changing the source of two raw materials.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
MISEQDX UNIVERSAL KIT 1.0 (DEN130042)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS 139-VARIANT ASSAY (K124006)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX PLATFORM (DEN130011)Illumina, Inc.2013-11-19
ILLUMINA MISEQDX CYSTIC FIBROSIS CLINICAL SEQUENCING ASSAY (K132750)Illumina, Inc.2013-11-19
ILLUMINA BEADXPRESS SYSTEM (K093128)Illumina, Inc.2010-04-28
ILLUMINA VERNCODE GENOTYPING TEST FOR FACOR V AND FACTOR II (K093129)Illumina, Inc.2010-04-28